Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

2,461

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

2,461 results for “Rheumatoid Arthritis”

Learn how ShareScore rates datasets ↗
zenodo40/100

Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes - Supplementary Figure 4 representative histology images

<p>This includes the original full-size representative histology images presented in Supplementary Fig. 4 for&nbsp;the paper &quot;Zhang*, Jonsson*, Nathan*, Millard*, et al,&nbsp;Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes, Nature, 2023<strong>&quot;</strong>.</p> <p>Representative fragments from patients in each CTAP, showing composite and individual staining of each marker in the lymphocyte panel&nbsp;or stromal cell panel. A total of 150 fragments from 36 individuals (mean 4.2 fragments per individual, range 2-9 fragments per individual) were stained in batches and analyzed as a single cohort.</p>

opencc-by-4.0Sep 2023View details →
ClinicalTrials.gov40/100

Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH)

ClinicalTrials.gov study NCT02332590. IPD Sharing: YES. Countries: 15. Publications: 12.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Comorbidities and Outcomes in Early Rheumatoid Arthritis

ClinicalTrials.gov study NCT03675516. IPD Sharing: NO. Countries: 1. Publications: 3.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov40/100

AMG 162 (Denosumab) Phase 3 Study (DESIRABLE Study) in Participants With Rheumatoid Arthritis on Disease-modifying Antirheumatic Drugs (DMARDs) Treatment

ClinicalTrials.gov study NCT01973569. IPD Sharing: YES. Countries: 1. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Adults With Rheumatoid Arthritis

ClinicalTrials.gov study NCT02049138. IPD Sharing: YES. Countries: 18. Publications: 3.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND)

ClinicalTrials.gov study NCT01146652. IPD Sharing: YES. Countries: 40. Publications: 5.

controlledIPD-YESFeb 2026View details →
zenodo36/100

Accompanied data files used in the paper "Analysis of chromatin organization and gene expression in T cells identifies functional genes for rheumatoid arthritis"

<p>lists of source file used in the paper &quot;Analysis of chromatin organization and gene expression in T cells identifies functional genes for rheumatoid arthritis&quot; by Jing Yang, Amanda McGovern, Paul Martin, Kate Duffus, Xiangyu Ge, Peyman Zarrineh, Andrew P Morris, Antony Adamson, Peter Fraser, Magnus Rattray &amp; Stephen Eyre. The paper has been accepted by Nature Communications.</p>

opencc-by-4.0May 2020View details →
dryad36/100

Data from: Large-scale meta-analysis on rheumatoid arthritis across East Asian and European populations

<p><span><span><span><b>Objective:</b> Nearly 110 susceptibility loci for rheumatoid arthritis (RA) with modest effect sizes have been identified by population-based genetic association studies, suggesting a large number of undiscovered variants behind a highly polygenic genetic architecture of RA. Here, we performed the largest-ever trans-ancestral meta-analysis with the aim to identify new RA loci and to better understand RA biology underlying genetic associations.</span></span></span></p> <p><span><span><span><b>Methods:</b> Genome-wide RA association summary statistics in three large case-control collections consisting of 311,292 individuals of Korean, Japanese, and European populations were used in an inverse-variance-weighted fixed-effects meta-analysis. Several computational analyses using public omics resources were conducted to prioritize causal variants and genes, RA variant-implicating features (tissues, pathways, and transcription factors), and potentially repurposable drugs for RA treatment. </span></span></span></p> <p><span><span><span><b>Results:</b> We identified 11 new RA susceptibility loci that explained 6.9% and 1.8% of the SNP-based heritability in East Asians and Europeans, respectively, and confirmed 71 known non-HLA susceptibility loci, identifying 90 independent association signals. The RA variants were preferentially located in binding sites of various transcription factors and in cell type-specific transcription-activation histone marks that simultaneously highlighted the importance of CD4<sup>+</sup> T-cell activation and the potential role of non-immune organs in RA pathogenesis. A total of 615 plausible effector genes, based on gene-based associations, expression-associated variants, and chromatin interaction, included targets of drugs approved for RA treatments and potentially repurposable drugs approved for other indications.</span></span></span></p> <p><span><span><span><b>Conclusion:</b> Our findings provide useful insights regarding RA genetic etiology and variant-driven RA pathogenesis.</span></span></span></p>

opencc-zeroDec 2020View details →
dryad36/100

Data from: Multi-omics analyses on rheumatoid arthritis in CD4+ T cells

<p><strong>Objective</strong>: CD4+ T cells have been suggested as the most disease-relevant cell type in rheumatoid arthritis (RA) in which RA-risk non-coding variants exhibit allele-specific effects on regulation of RA-driving genes. This study aimed to understand RA-specific signatures in CD4+ T cells using multi-omics data, interpreting inter-omics relationships in shaping the RA transcriptomic landscape.</p> <p><span><span><span><b>Methods</b>: We profiled genome-wide variants, gene expression, and DNA methylation in CD4<sup>+</sup> T cells from 82 RA patients and 40 healthy controls using high-throughput technologies. We investigated differentially expressed genes (DEGs) and differentially methylated regions (DMRs) in RA and localized quantitative trait loci (QTLs) for expression and methylation. We then integrated these based on individual-level correlations to inspect DEG-regulating sources and investigated the potential regulatory roles of RA-risk variants by a partitioned-heritability enrichment analysis with RA genome-wide association summary statistics.</span></span></span></p> <p><span><span><span><b>Results</b>: A large number of RA-specific DEGs were identified (n=2,575), highlighting T-cell differentiation and activation pathways. RA-specific DMRs, preferentially located in T-cell regulatory regions, were correlated with the expression levels of 548 DEGs mostly in the same topologically associating domains. In addition, expressional variances in 771 and 83 DEGs were partially explained by expression QTLs for DEGs and methylation QTLs for DEG-correlated DMRs, respectively. A large number of RA variants were moderately to strongly correlated with meQTLs. DEG-correlated DMRs, enriched with meQTLs, had strongly enriched heritability of RA.</span></span></span></p> <p><span><span><span><b>Conclusion</b>: Our findings revealed that the methylomic changes, driven by RA heritability-explaining variants, shape the differential expression of a substantial fraction of DEGs in CD4<sup>+</sup> T cells in RA patients, reinforcing the importance of a multi-dimensional approach in disease-relevant tissues.</span></span></span></p>

opencc-zeroJan 2021View details →
zenodo36/100

Data Integration to Identify and Prioritize Potential Regulatory Variants for Rheumatoid Arthritis in a Post-GWAS era

<p>The Data set contain data related to the SNPs in linkage disequilibrium with published GWAS rheumatoid arthritis SNPs and the subsequent annotation and pathway analysis files performed to identify putative &#39;missed&#39; variants of rheumatoid arthritis.&nbsp;</p>

opencc-by-4.0Jan 2022View details →
ClinicalTrials.gov36/100

A Non-Interventional Study in Rheumatoid Arthritis Patients Treated With Tocilizumab (RoActemra/Actemra)

ClinicalTrials.gov study NCT01613378. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

A Study for Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate Therapy

ClinicalTrials.gov study NCT00785928. IPD Sharing: Not stated. Countries: 12. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Study for Validation of Standardized Questionnaires on Depression and Investigation of the Frequency of Depression in Rheumatoid Arthritis (RA) Participants

ClinicalTrials.gov study NCT02485483. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis

ClinicalTrials.gov study NCT02137226. IPD Sharing: Not stated. Countries: 15. Publications: 6.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With Methotrexate

ClinicalTrials.gov study NCT00628095. IPD Sharing: YES. Countries: 7. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

ClinicalTrials.gov study NCT01232569. IPD Sharing: Not stated. Countries: 22. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Study Of The Effects Of Atorvastatin On Cholesterol Levels In Rheumatoid Arthritis Patients Taking CP-690,550

ClinicalTrials.gov study NCT01059864. IPD Sharing: Not stated. Countries: 2. Publications: 12.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor Therapy

ClinicalTrials.gov study NCT00689728. IPD Sharing: Not stated. Countries: 10. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Multiple Ascending Doses of Rozibafusp Alfa (AMG 570) in Adults With Rheumatoid Arthritis

ClinicalTrials.gov study NCT03156023. IPD Sharing: YES. Countries: 2. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Efficacy and Safety Study of BMS-986142 in Patients With Moderate to Severe Rheumatoid Arthritis

ClinicalTrials.gov study NCT02638948. IPD Sharing: Not stated. Countries: 17. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record